The Multifaceted Actions of PVP–Curcumin for Treating Infections
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116140 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Magdalena Metzger und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria. Hauptthemen laut MEDLINE: Curcumin, Photosensitizing Agents, Rec A Recombinases, Ciprofloxacin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Research Promotion Agency, FFG innovation check program.
Abstract (Originalsprache)
Curcumin is a natural compound that is considered safe and may have potential health benefits; however, its poor stability and water insolubility limit its therapeutic applications. Different strategies aim to increase its water solubility. Here, we tested the compound PVP–curcumin as a photosensitizer for antimicrobial photodynamic therapy (aPDT) as well as its potential to act as an adjuvant in antibiotic drug therapy. Gram-negative E. coli K12 and Gram-positive S. capitis were subjected to aPDT using various PVP–curcumin concentrations (1–200 µg/mL) and 475 nm blue light (7.5–45 J/cm2). Additionally, results were compared to aPDT using 415 nm blue light. Gene expression of recA and umuC were analyzed via RT-qPCR to assess effects on the bacterial SOS response. Further, the potentiation of Ciprofloxacin by PVP–curcumin was investigated, as well as its potential to prevent the emergence of antibiotic resistance. Both bacterial strains were efficiently reduced when irradiated with 415 nm blue light (2.2 J/cm2) and 10 µg/mL curcumin. Using 475 nm blue light, bacterial reduction followed a biphasic effect with higher efficacy in S. capitis compared to E. coli K12. PVP–curcumin decreased recA expression but had limited effect regarding enhancing antibiotic treatment or impeding resistance development. PVP–curcumin demonstrated effectiveness as a photosensitizer against both Gram-positive and Gram-negative bacteria but did not modulate the bacterial SOS response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
- Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
- Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.
- Planta Naturstoffe Vertriebs GmbH, 1230 Vienna, Austria.
ORCID-Profile: Magdalena Metzger, Johannes Grillari
Förderung
- Austrian Research Promotion Agency
- FFG innovation check program
Zitieren
APA
Metzger, M., Manhartseder, S., Krausgruber, L., Scholze, L., Fuchs, D., Wagner, C., Stainer, M., Grillari, J., Kubin, A., Wightman, L., & Dungel, P. (2024). The Multifaceted Actions of PVP–Curcumin for Treating Infections. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116140
Vancouver
Metzger M, Manhartseder S, Krausgruber L, Scholze L, Fuchs D, Wagner C, et al. The Multifaceted Actions of PVP–Curcumin for Treating Infections. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116140
BibTeX
@article{Metzger2024,
author = {Metzger, Magdalena and Manhartseder, Stefan and Krausgruber, Leonie and Scholze, Lea and Fuchs, David and Wagner, Carina and Stainer, Michaela and Grillari, Johannes and Kubin, Andreas and Wightman, Lionel and Dungel, Peter},
title = {The Multifaceted Actions of PVP–Curcumin for Treating Infections},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116140}
}
EUVIMED